Everett Harris & Co
- SEC CIK
- 0001009254
- Latest filing
- Aug 3, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Everett Harris & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 80,341
- Value
- $7.27M
- % of portfolio
- 0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 80,341 | $7.27M | 0.1% | +2,069+2.6% | Added | Holders |
| Q1 2026 | 78,272 | $6.27M | 0.1% | −6,386−7.5% | Reduced | Holders |
| Q4 2025 | 84,658 | $7.22M | 0.1% | −2,967−3.4% | Reduced | Holders |
| Q3 2025 | 87,625 | $6.81M | 0.1% | −80−0.1% | Reduced | Holders |
| Q2 2025 | 87,705 | $6.86M | 0.1% | −670−0.8% | Reduced | Holders |
| Q1 2025 | 88,375 | $6.41M | 0.1% | −2,218−2.4% | Reduced | Holders |
| Q4 2024 | 90,593 | $6.71M | 0.1% | −301−0.3% | Reduced | Holders |
| Q3 2024 | 90,894 | $6.00M | 0.1% | −7,039−7.2% | Reduced | Holders |
| Q2 2024 | 97,933 | $9.05M | 0.1% | −72,223−42.4% | Reduced | Holders |
| Q1 2024 | 170,156 | $16.3M | 0.2% | −850.0% | Reduced | Holders |
| Q4 2023 | 170,241 | $13.0M | 0.2% | −678−0.4% | Reduced | Holders |
| Q3 2023 | 170,919 | $11.8M | 0.2% | +4,161+2.5% | Added | Holders |
| Q2 2023 | 166,758 | $15.7M | 0.2% | −6,090−3.5% | Reduced | Holders |
| Q1 2023 | 172,848 | $14.3M | 0.2% | −14,675−7.8% | Reduced | Holders |
| Q4 2022 | 187,523 | $14.0M | 0.2% | +565+0.3% | Added | Holders |
| Q3 2022 | 186,958 | $15.4M | 0.3% | −107−0.1% | Reduced | Holders |
| Q2 2022 | 187,065 | $17.8M | 0.3% | +408+0.2% | Added | Holders |
| Q1 2022 | 186,657 | $22.0M | 0.3% | −700.0% | Reduced | Holders |
| Q4 2021 | 186,727 | $24.2M | 0.3% | −345−0.2% | Reduced | Holders |
| Q3 2021 | 187,072 | $21.2M | 0.3% | −500.0% | Reduced | Holders |
| Q2 2021 | 187,122 | $19.4M | 0.3% | −3,756−2.0% | Reduced | Holders |
| Q1 2021 | 190,878 | $16.0M | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.